{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:12:13Z","timestamp":1762981933819,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102149"],"award-info":[{"award-number":["82102149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Excellent Youth Talent Cultivation Program of Innovation in Health Science and Technology of Henan Province","award":["YXKC2022061"],"award-info":[{"award-number":["YXKC2022061"]}]},{"name":"the Key Program of Medical Science and Technique Foundation of Henan Province","award":["SBGJ202002062"],"award-info":[{"award-number":["SBGJ202002062"]}]},{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2019A1515011143"],"award-info":[{"award-number":["2019A1515011143"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12713-9","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:02:17Z","timestamp":1724050937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjiao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"12713_CR1","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/1097-0142(197911)44:5<1839::AID-CNCR2820440543>3.0.CO;2-0","volume":"44","author":"JJ Kepes","year":"1979","unstructured":"Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer. 1979;44:1839\u201352. https:\/\/doi.org\/10.1002\/1097-0142(197911)44:5%3C;1839::aid-cncr2820440543%3E;3.0.co;2-0.","journal-title":"Cancer"},{"key":"12713_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803\u201320. https:\/\/doi.org\/10.1007\/s00401-016-1545-1.","journal-title":"Acta Neuropathol"},{"key":"12713_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neurooncology. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106.","journal-title":"Neurooncology"},{"key":"12713_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40478-021-01308-1","volume":"10","author":"A Ebrahimi","year":"2022","unstructured":"Ebrahimi A, Korshunov A, Reifenberger G, et al. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. Acta Neuropathol Commun. 2022;10:5. https:\/\/doi.org\/10.1186\/s40478-021-01308-1.","journal-title":"Acta Neuropathol Commun"},{"key":"12713_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41374-021-00708-0","volume":"102","author":"S Mahajan","year":"2022","unstructured":"Mahajan S, Dandapath I, Garg A, Sharma MC, Suri V, Sarkar C. The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics. Lab Invest. 2022;102:670\u201381. https:\/\/doi.org\/10.1038\/s41374-021-00708-0.","journal-title":"Lab Invest"},{"key":"12713_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/bpa.12639","volume":"29","author":"JJ Phillips","year":"2019","unstructured":"Phillips JJ, Gong H, Chen K, et al. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Brain Pathol. 2019;29:85\u201396. https:\/\/doi.org\/10.1111\/bpa.12639.","journal-title":"Brain Pathol"},{"key":"12713_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","volume":"373","author":"DM Hyman","year":"2015","unstructured":"Hyman DM, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. N Engl J Med. 2015;373:726\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1502309.","journal-title":"N Engl J Med"},{"key":"12713_CR8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694\u2013703. https:\/\/doi.org\/10.1056\/NEJMoa1210093.","journal-title":"N Engl J Med"},{"key":"12713_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/cns","volume":"6","author":"NF Brown","year":"2017","unstructured":"Brown NF, Carter T, Mulholland P. Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma. CNS Oncol. 2017;6:5\u20139. https:\/\/doi.org\/10.2217\/cns. \u2013 2016\u20130031.","journal-title":"CNS Oncol"},{"key":"12713_CR10","doi-asserted-by":"publisher","first-page":"CNS10","DOI":"10.2217\/cns-2017-0032","volume":"7","author":"RV Lukas","year":"2018","unstructured":"Lukas RV, Merrell RT. BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma. CNS Oncol. 2018;7:CNS10. https:\/\/doi.org\/10.2217\/cns-2017-0032.","journal-title":"CNS Oncol"},{"key":"12713_CR11","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1200\/JCO.2013.51.1766","volume":"34","author":"EQ Lee","year":"2016","unstructured":"Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S. Successful treatment of a progressive BRAF V600E-Mutated anaplastic Pleomorphic Xanthoastrocytoma with Vemurafenib Monotherapy. J Clin Oncol. 2016;34:e87\u201389. https:\/\/doi.org\/10.1200\/JCO.2013.51.1766.","journal-title":"J Clin Oncol"},{"key":"12713_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/bpa.12217","volume":"25","author":"CM Ida","year":"2015","unstructured":"Ida CM, Rodriguez FJ, Burger PC, et al. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up. Brain Pathol. 2015;25:575\u201386. https:\/\/doi.org\/10.1111\/bpa.12217.","journal-title":"Brain Pathol"},{"key":"12713_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.ejso.2015.09.012","volume":"41","author":"E Tabouret","year":"2015","unstructured":"Tabouret E, Bequet C, Denicola\u00ef E, et al. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Eur J Surg Oncol. 2015;41:1685\u201390. https:\/\/doi.org\/10.1016\/j.ejso.2015.09.012.","journal-title":"Eur J Surg Oncol"},{"key":"12713_CR14","doi-asserted-by":"publisher","first-page":"558162","DOI":"10.3389\/fonc.2020.558162","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan J, Liu L, Wang W, et al. Radiomic features from Multi-parameter MRI Combined with Clinical parameters Predict Molecular subgroups in patients with Medulloblastoma. Front Oncol. 2020;10:558162. https:\/\/doi.org\/10.3389\/fonc.2020.558162.","journal-title":"Front Oncol"},{"key":"12713_CR15","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1007\/s00330-018-5351-0","volume":"28","author":"SC Thust","year":"2018","unstructured":"Thust SC, Hassanein S, Bisdas S, et al. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II\/III glioma: volumetric segmentation versus two-dimensional region of interest analysis. Eur Radiol. 2018;28:3779\u201388. https:\/\/doi.org\/10.1007\/s00330-018-5351-0.","journal-title":"Eur Radiol"},{"key":"12713_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2214\/AJR.17.18457","volume":"210","author":"JE Villanueva-Meyer","year":"2018","unstructured":"Villanueva-Meyer JE, Wood MD, Choi BS, et al. Features and IDH Mutational Status of Grade II diffuse gliomas: impact on diagnosis and prognosis. AJR Am J Roentgenol. 2018;210:621\u20138. https:\/\/doi.org\/10.2214\/AJR.17.18457.","journal-title":"AJR Am J Roentgenol"},{"key":"12713_CR17","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3174\/ajnr.A7324","volume":"42","author":"W Huang","year":"2021","unstructured":"Huang W, Cai J, Lin N, et al. Identification of BRAF p. V600E-Mutant and wild-type by MR Imaging in Pleomorphic Xanthoastrocytoma and Anaplastic Pleomorphic Xanthoastrocytoma. AJNR Am J Neuroradiol. 2021;42:2152\u20139. https:\/\/doi.org\/10.3174\/ajnr.A7324.","journal-title":"AJNR Am J Neuroradiol"},{"key":"12713_CR18","doi-asserted-by":"publisher","unstructured":"Ma C, Feng R, Chen H et al. BRAF V600E, TERT, and IDH2 mutations in Pleomorphic Xanthoastrocytoma: observations from a large case-series study, World neurosurgery 120 (2018) e1225-1225e1233. https:\/\/doi.org\/10.1016\/j.wneu.2018.09.050","DOI":"10.1016\/j.wneu.2018.09.050"},{"key":"12713_CR19","doi-asserted-by":"publisher","unstructured":"Mukherjee P, Miller JH, Shimony JS et al. Normal Brain Maturation during Childhood: Developmental Trends Characterized with Diffusion-Tensor MR Imaging [J]. Radiology.2001;221(2):349\u2009\u2013\u200958. https:\/\/doi.org\/10.1148\/radiol.2212001702","DOI":"10.1148\/radiol.2212001702"},{"key":"12713_CR20","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.3174\/ajnr.A4011","volume":"35","author":"W Moore","year":"2014","unstructured":"Moore W, Mathis D, Gargan L, et al. Pleomorphic xanthoastrocytoma of childhood: MR imaging and diffusion MR imaging features. AJNR Am J Neuroradiol. 2014;35:2192\u20136. https:\/\/doi.org\/10.3174\/ajnr.A4011.","journal-title":"AJNR Am J Neuroradiol"},{"key":"12713_CR21","doi-asserted-by":"publisher","first-page":"14275","DOI":"10.1038\/s41598-018-32273-w","volume":"8","author":"J Yan","year":"2018","unstructured":"Yan J, Cheng J, Liu F, Liu X. Pleomorphic xanthoastrocytomas of adults: MRI features, molecular markers, and clinical outcomes. Sci Rep. 2018;8:14275. https:\/\/doi.org\/10.1038\/s41598-018-32273-w.","journal-title":"Sci Rep"},{"key":"12713_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/02688697.2013.776666","volume":"27","author":"P Gallo","year":"2013","unstructured":"Gallo P, Cecchi PC, Locatelli F, et al. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors. Br J Neurosurg. 2013;27:759\u201364. https:\/\/doi.org\/10.3109\/02688697.2013.776666.","journal-title":"Br J Neurosurg"},{"key":"12713_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1227\/00006123-199405000-00005","volume":"34","author":"I Fried","year":"1994","unstructured":"Fried I, Kim JH, Spencer DD. Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery. 1994;34:815\u201323. https:\/\/doi.org\/10.1227\/00006123-199405000-00005. discussion 823\u2013824.","journal-title":"Neurosurgery"},{"key":"12713_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","volume":"111","author":"KL Chaichana","year":"2009","unstructured":"Chaichana KL, Parker SL, Olivi A, Qui\u00f1ones-Hinojosa A. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg. 2009;111:282\u201392. https:\/\/doi.org\/10.3171\/2009.2.JNS081132.","journal-title":"J Neurosurg"},{"key":"12713_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00234-006-0191-z","volume":"49","author":"AM Crespo-Rodr\u00edguez","year":"2007","unstructured":"Crespo-Rodr\u00edguez AM, Smirniotopoulos JG, Rushing EJ. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology. 2007;49:307\u201315. https:\/\/doi.org\/10.1007\/s00234-006-0191-z.","journal-title":"Neuroradiology"},{"key":"12713_CR26","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/(SICI)1097-0142(19961215)78:12<2551::AID-CNCR15>3.0.CO;2-V","volume":"78","author":"B Lach","year":"1996","unstructured":"Lach B, Duggal N, DaSilva VF, Benoit BG. Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors. A report of three cases. Cancer. 1996;78:2551\u201363.","journal-title":"Cancer"},{"key":"12713_CR27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.jocn.2012.09.046","volume":"20","author":"N Montano","year":"2013","unstructured":"Montano N, Papacci F, Cioni B, et al. Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features. J Clin Neurosci. 2013;20:1605\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2012.09.046.","journal-title":"J Clin Neurosci"},{"key":"12713_CR28","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1148\/radiol.2452061535","volume":"245","author":"PD Humphries","year":"2007","unstructured":"Humphries PD, Sebire NJ, Siegel MJ, Olsen \u00d8E. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007;245:848\u201354. https:\/\/doi.org\/10.1148\/radiol.2452061535.","journal-title":"Radiology"},{"key":"12713_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejrad.2019.03.006","volume":"114","author":"H Chen","year":"2019","unstructured":"Chen H, Hu W, He H, Yang Y, Wen G, Lv X. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Eur J Radiol. 2019;114:152\u20139. https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.006.","journal-title":"Eur J Radiol"},{"key":"12713_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clinimag.2008.06.035","volume":"33","author":"G Pavlisa","year":"2009","unstructured":"Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D. The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging. 2009;33:96\u2013101. https:\/\/doi.org\/10.1016\/j.clinimag.2008.06.035.","journal-title":"Clin Imaging"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12713-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12713-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12713-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T19:02:54Z","timestamp":1724094174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12713-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12713"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12713-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"7 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research is approval by the Human Scientific Ethics Committee of the First Affiliated Hospital of Zhengzhou University (approval number: 2019-KY-176).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consents were obtained from the patients or legal guardian.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1022"}}